These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26143161)

  • 1. Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.
    Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Mijares V; Carnero-López B; Gómez-Acebo I; Dierssen-Sotos T; Remuzgo-Martínez S; Blanco R; Pina T; González-Juanatey C; Llorca J; González-Gay MA
    Rheumatol Int; 2015 Dec; 35(12):2069-78. PubMed ID: 26143161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
    Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Carnero-López B; Palmou-Fontana N; Gómez-Acebo I; Blanco R; Rueda-Gotor J; Pina T; González-Juanatey C; Llorca J; González-Gay MÁ
    Clin Exp Rheumatol; 2014; 32(5):640-6. PubMed ID: 25190453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
    Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Arias-Bajo M; Rueda-Gotor J; Paz-Carreira J; González-Juanatey C; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2014; 32(2):231-6. PubMed ID: 24295386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
    Genre F; Miranda-Filloy JA; López-Mejias R; Carnero-López B; Ochoa R; Rueda J; González-Juanatey C; Blanco R; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2013; 31(4):532-7. PubMed ID: 23484462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy.
    Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Rueda-Gotor J; González-Juanatey C; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2014; 32(2):218-24. PubMed ID: 24351434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy.
    Genre F; López-Mejías R; Miranda-Filloy JA; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Rueda J; González-Juanatey C; Llorca J; González-Gay MÁ
    Clin Exp Rheumatol; 2013; 31(6):913-8. PubMed ID: 23981480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
    Miranda-Filloy JA; López-Mejias R; Genre F; Carnero-López B; Ochoa R; Diaz de Terán T; González-Juanatey C; Blanco R; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2013; 31(3):365-71. PubMed ID: 23294554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
    Genre F; López-Mejías R; Miranda-Filloy JA; Carnero-López B; Gómez-Acebo I; Blanco R; Ochoa R; Rueda J; González-Juanatey C; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2013; 31(5):749-55. PubMed ID: 23806325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis.
    Genre F; Armesto S; Corrales A; López-Mejías R; Remuzgo-Martínez S; Pina T; Ubilla B; Mijares V; Martín-Varillas JL; Rueda-Gotor J; Portilla V; Dierssen-Sotos T; González-López MA; González-Vela MDC; Blanco R; Llorca J; Hernández JL; González-Gay MÁ
    J Dermatolog Treat; 2017 Dec; 28(8):726-730. PubMed ID: 28489469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.
    Klimiuk PA; Sierakowski S; Domysławska I; Fiedorczyk M; Chwiećko J
    Arch Immunol Ther Exp (Warsz); 2004; 52(1):36-42. PubMed ID: 15053231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
    Miranda-Filloy JA; López-Mejias R; Genre F; Carnero-López B; Ochoa R; Diaz de Terán T; González-Juanatey C; Blanco R; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2013; 31(4):538-45. PubMed ID: 23711190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade.
    Syngle A; Vohra K; Sharma A; Kaur L
    Clin Rheumatol; 2010 Jul; 29(7):763-70. PubMed ID: 20204669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population].
    Guzmán-Guzmán IP; Zaragoza-García O; Vences-Velázquez A; Castro-Alarcón N; Muñoz-Valle JF; Parra-Rojas I
    Med Clin (Barc); 2016 Nov; 147(10):427-434. PubMed ID: 27576535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Garcia-Unzueta MT; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
    Clin Exp Rheumatol; 2006; 24(4):373-9. PubMed ID: 16956426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effect.
    Genre F; López-Mejías R; Rueda-Gotor J; Miranda-Filloy JA; Ubilla B; Carnero-López B; Palmou-Fontana N; Gómez-Acebo I; Blanco R; Pina T; Ochoa R; González-Juanatey C; Llorca J; González-Gay MA
    Mediators Inflamm; 2014; 2014():798060. PubMed ID: 24976690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.
    Genre F; López-Mejías R; Miranda-Filloy JA; Ubilla B; Carnero-López B; Blanco R; Pina T; González-Juanatey C; Llorca J; González-Gay MA
    Biomed Res Int; 2014; 2014():860651. PubMed ID: 24757680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients.
    Miranda-Filloy JA; Llorca J; Carnero-López B; González-Juanatey C; Blanco R; González-Gay MA
    Clin Exp Rheumatol; 2012; 30(6):850-5. PubMed ID: 22765845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.
    Garg N; Krishan P; Syngle A
    Clin Rheumatol; 2015 Jun; 34(6):1065-71. PubMed ID: 25771851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P; Hrycek A
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
    Macías I; García-Pérez S; Ruiz-Tudela M; Medina F; Chozas N; Girón-González JA
    J Rheumatol; 2005 Nov; 32(11):2102-8. PubMed ID: 16265686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.